INTRODUCTION: A study conducted in the National Institute of Health Quality Control for the fiscal analysis of injectable drugs identified an excessive percentage of losses (analysis not performed). An attempt to identify factors associated with these losses was performed. METHODS: The presence of irregularities at the time of the apprehension of the drug (dependent variable) was investigated in relation to the region where the drug came from, the reason for drug apprehension and the drug ATC classification (independent variables). RESULTS: The North region contributed with only 2.2% of all drugs sent to analysis, 50% of which could not be conducted. Only 1.4% of the drugs sent by the Middle-West region had problems in the apprehension process. CONCLUSION: An efficient implementation of a quality program in Health Surveillance in the state of Goiás was detected in the analytical phase, allowing the laboratory to complete the inspection cycle.
Drugs; Health Surveillance; Product Arrest
